121Women's cardiovascular health in 2025: <i>Advancements achieved, challenges ahead</i>.2026 · Europe PMC
123Treating Psychological Factors in Patients With Heart Disease: Where Have We Been, How Shall We Proceed?2026 · Europe PMC
124Fatty acid synthase in cardiovascular disease: from molecular mechanisms to therapeutic targeting.2026 · Europe PMC
125Closing the Gap: Examining Representation of Women in Ischemic Heart Disease Guideline Studies.2026 · Europe PMC
126Cardiorenal Protection in Type 2 Diabetes: A Systematic Review Comparing Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors.2026 · Europe PMC
127Emerging Roles of Dystroglycan in Cardiac Remodeling, Fibrosis, and Heart Failure.2026 · Europe PMC
128Menopause Hormone Therapy in Women With Cardiovascular Risk Factors or Established Ischemic Heart Disease: A Joint FIGO and WHF Position Paper.2026 · Europe PMC
129Mechanical thrombectomy in cancer-associated pulmonary embolism: reassuring safety, unclear benefit.2026 · Europe PMC
130Epicardial adipose tissue as a metabolically active visceral fat depot: an emerging target in cardiovascular disease.2026 · Europe PMC
131Decision-making for older adults with advanced heart disease: a framework for balancing benefit versus futility.2026 · Europe PMC
133GLP-1 receptor agonists beyond glycemic control: integrated cardio-renal-metabolic protection across the cardiovascular kidney metabolic continuum.2026 · Europe PMC
134Cardiac Implantable Electronic Devices Management in Older Adults ≥75 Years Old: From Underrepresentation in Clinical Trials to Overrepresentation in Contemporary Clinical Practice.2026 · Europe PMC
135Multitarget mechanisms and clinical integration of traditional Chinese medicine in cardiac rehabilitation: a narrative review.2026 · Europe PMC
136Intersecting Molecular Pathways in Cardiovascular Disease and Diabetes Mellitus: Emerging Roles of Inflammation and Therapeutics.2026 · Europe PMC
139The Intersection of Cardiology and Sleep Medicine: Impact of Sleep-Disordered Breathing on Heart Failure Outcomes.2026 · Europe PMC
140Peripartum interventions for elevated blood pressure in women with hypertensive disorders of pregnancy: a systematic review and meta-analysis.2026 · Europe PMC
142Adjudicating Heart Failure as an End Point in Dialysis Trials: More Signal, Less Noise.2026 · Europe PMC
143A review bridging pharmacokinetics, preclinical data, and human evidence on curcuminoids in cardiovascular disease.2026 · Europe PMC
144Best evidence summary of digital health interventions for self-management in patients with coronary artery disease.2026 · Europe PMC
145Public availability of trial-design and clinical-context information in contemporary lipoprotein(a)-targeted cardiovascular trials: A cross-sectional meta-research study.2026 · Europe PMC
146Calcium dysregulation in diabetic cardiomyopathy & heart failure with preserved ejection fraction.2026 · Europe PMC
147Bibliometric Trends in Inflammasome‑Driven Pyroptosis and Cardiovascular Disease.2026 · Europe PMC
148The effects of menopausal hormone therapy on cardiovascular disease, cancer, cognition and depression in younger women: A systematic review.2026 · Europe PMC
149Roles of inflammation and metabolic dysfunction in cardiovascular diseases: molecular mechanisms and therapeutic targets.2026 · Europe PMC
150Cardiovascular Effects of Glucagon Receptor Signaling Alone and Combined With Glucagon-Like Peptide-1 Receptor Signaling in Multiagonists: A Narrative Review With a Translational Focus.2026 · Europe PMC
152Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.2026 · Europe PMC
153Icosapent ethyl activates GPR120 to improve post-myocardial infarction cardiac remodeling by suppressing CXCR3<sup>+</sup> inflammatory cells.2026 · Europe PMC
154A Randomized Trial to Investigate the Effects of Low-Dose Colchicine in Patients with Hypertension: Rationale and Design of the COlchicine and HypERtENsion Trial (COHERENT).2026 · Europe PMC
155Redefining Uric Acid and Cardiovascular Risk : Vascular Gout and Crystal-Driven Vascular Inflammation in Asymptomatic Hyperuricemia2026 · Europe PMC
156Digital heart initiative: an ecosystem for digital discovery and precision medicine in cardiology.2026 · Europe PMC
157From Periodontal Inflammation to Atrial Fibrillation: Molecular Links Through Thrombospondin-1, Galectin-3, and SGLT2-Related Pathways.2026 · Europe PMC
159C-reactive protein in cardiovascular disease: clinical associations, conformation-dependent biology, and therapeutic perspectives.2026 · Europe PMC
160Major Adverse Cognitive Events (MACE-Cog): A New "MACE" Framework for Cognitive Outcomes in Cardiovascular Diseases and Stroke.2026 · Europe PMC
161Chinese Expert Consensus on the Clinical Application of Finerenone in Geriatric Comorbidities: Geriatrics Branch of Chinese Medical Association, Cardiovascular Group of Geriatrics Branch of Chinese Medical Association.2026 · Europe PMC
162Exercise Training Across the Hypertensive Heart Disease Continuum: Clinical Evidence and Implications for Prescription.2026 · Europe PMC
163PCSK9 inhibition after heart transplantation: how low does low-density lipoprotein cholesterol need to go for cardiac allograft vasculopathy prevention?2026 · Europe PMC
165Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients: An Analysis From the EMPEROR-Reduced Trial.2026 · Europe PMC
167Feasibility of the Aktivplan Digital Health Intervention for Supporting Regular Physical Activity Following Phase II Rehabilitation: Randomized Controlled Pilot Feasibility Study (ACTIVE-CaRe Pilot).2026 · Europe PMC
168Combined use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for cardiovascular protection.2026 · Europe PMC
169Long-term clinical benefit of mavacamten for hypertrophic cardiomyopathy in a patient with <i>RAF1</i>-associated Noonan syndrome-case report.2026 · Europe PMC
170Editorial: Clinical trials in cardiovascular medicine: 2025-addressing residual cardiovascular risks through precision-guided approaches.2026 · Europe PMC
171Hormonal Modulation in Chronic Coronary Syndrome: From Neurohormonal Activation to Endocrine Targets.2026 · Europe PMC
172Cardiac Rehabilitation-Current Paradigms and Challenges Across the Cardiovascular Continuum.2026 · Europe PMC
173Tocotrienol-rich fraction of vitamin E in diabetes and cardiovascular disease: From molecular mechanisms to clinical application.2026 · Europe PMC
174Rivaroxaban for the prevention of atherothrombotic events in advanced CKD: are we off TRACK?2026 · Europe PMC
175Nutritional Prevention of Oxidative Stress-Induced Cardiotoxicity in Pediatric Cardio-Oncology: Molecular Mechanisms and Translational Perspectives-A Narrative Review.2026 · Europe PMC
176AI-guided ethnopharmacology for cardiovascular drug discovery: from biomedical data to experimental validation2026 · Europe PMC
177Current Perspectives on the Role of Collagen Peptide Fragments in Health and Disease.2026 · Europe PMC
178Cell-Based Therapies for Cardiac and Vascular Regeneration in Cardiovascular Disease: Recent Advances, Translational Barriers, and Future Directions.2026 · Europe PMC
179Effect of Yoga on Ventricular Premature Complex Burden and Quality of Life: The VPC-Yoga Study.2026 · Europe PMC
180Cardiovascular outcomes and acute human metapneumovirus infection in adults: A systematic literature review.2026 · Europe PMC